Back to compounds

COMPOUND PROFILE / SMALL MOLECULES

Tesofensine.

Research draft

Tesofensine is a small-molecule monoamine reuptake inhibitor investigated for obesity.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Tesofensine is a small-molecule monoamine reuptake inhibitor investigated for obesity.

CLASSIFICATIONSmall molecules
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It affects noradrenaline, dopamine and serotonin signalling.

Human research

A randomised oral obesity trial reported weight effects; this does not establish benefit-risk for unsupervised use.

Preclinical & other research

Animal and neurochemical work informed the appetite rationale.

Safety & unknowns

Heart rate, blood pressure, sleep and other monoamine-related effects are important.

Regulatory status

Authorisation must be checked by jurisdiction and product; no US or UK indication is established here.

Reported use & evidence

Research profile draft

The supplied Tesofensine profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds